Chronic myelogenous leukaemia (CML): an update.
Kumar, Lalit
Chronic myelogenous leukaemia (CML): an update. [electronic resource] - The National medical journal of India - 255-63 p. digital
Publication Type: Journal Article; Review
0970-258X
Antineoplastic Agents--therapeutic use
Benzamides
Bone Marrow Transplantation
Humans
Hydroxyurea--therapeutic use
Imatinib Mesylate
Interferon-alpha--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis
Piperazines--therapeutic use
Pyrimidines--therapeutic use
Risk Assessment
Risk Factors
Stem Cell Transplantation
Transplantation, Homologous
Chronic myelogenous leukaemia (CML): an update. [electronic resource] - The National medical journal of India - 255-63 p. digital
Publication Type: Journal Article; Review
0970-258X
Antineoplastic Agents--therapeutic use
Benzamides
Bone Marrow Transplantation
Humans
Hydroxyurea--therapeutic use
Imatinib Mesylate
Interferon-alpha--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis
Piperazines--therapeutic use
Pyrimidines--therapeutic use
Risk Assessment
Risk Factors
Stem Cell Transplantation
Transplantation, Homologous